Chimerix Inc (CMRX)
0.906
-0.02
(-2.09%)
USD |
NASDAQ |
Apr 24, 16:00
0.9031
0.00 (0.00%)
After-Hours: 20:00
Chimerix Enterprise Value: -101.89M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | -101.89M |
| April 23, 2024 | -100.16M |
| April 22, 2024 | -101.18M |
| April 19, 2024 | -103.81M |
| April 18, 2024 | -99.54M |
| April 17, 2024 | -102.06M |
| April 16, 2024 | -100.63M |
| April 15, 2024 | -101.12M |
| April 12, 2024 | -97.01M |
| April 11, 2024 | -94.39M |
| April 10, 2024 | -93.59M |
| April 09, 2024 | -94.39M |
| April 08, 2024 | -93.50M |
| April 05, 2024 | -90.82M |
| April 04, 2024 | -89.93M |
| April 03, 2024 | -89.93M |
| April 02, 2024 | -92.61M |
| April 01, 2024 | -89.04M |
| March 28, 2024 | -88.15M |
| March 27, 2024 | -92.61M |
| March 26, 2024 | -94.39M |
| March 25, 2024 | -94.88M |
| March 22, 2024 | -93.52M |
| March 21, 2024 | -97.42M |
| March 20, 2024 | -94.39M |
| Date | Value |
|---|---|
| March 19, 2024 | -97.07M |
| March 18, 2024 | -84.58M |
| March 15, 2024 | -80.12M |
| March 14, 2024 | -81.01M |
| March 13, 2024 | -78.33M |
| March 12, 2024 | -77.44M |
| March 11, 2024 | -72.09M |
| March 08, 2024 | -70.30M |
| March 07, 2024 | -70.30M |
| March 06, 2024 | -71.20M |
| March 05, 2024 | -74.77M |
| March 04, 2024 | -77.44M |
| March 01, 2024 | -78.33M |
| February 29, 2024 | -80.12M |
| February 28, 2024 | -72.09M |
| February 27, 2024 | -75.21M |
| February 26, 2024 | -76.55M |
| February 23, 2024 | -77.44M |
| February 22, 2024 | -77.77M |
| February 21, 2024 | -76.88M |
| February 20, 2024 | -74.22M |
| February 16, 2024 | -80.44M |
| February 15, 2024 | -90.22M |
| February 14, 2024 | -89.33M |
| February 13, 2024 | -91.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-137.34M
Minimum
Oct 20 2022
878.07M
Maximum
Feb 17 2021
129.28M
Average
30.64M
Median
Jul 11 2019
Enterprise Value Benchmarks
| UFP Technologies Inc | 1.665B |
| Dentsply Sirona Inc | 8.197B |
| Arbutus Biopharma Corp | 369.48M |
| Pacira BioSciences Inc | 1.448B |
| Karyopharm Therapeutics Inc | 104.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.16M |
| Revenue (Quarterly) | 0.004M |
| Total Expenses (Quarterly) | 20.81M |
| EPS Diluted (Quarterly) | -0.21 |
| Profit Margin (Quarterly) | -454.0K% |
| Earnings Yield | -102.6% |
| Normalized Earnings Yield | -102.65 |